The Live-Attenuated Influenza Vaccine (LAIV), also known as FluMist, has been shown to be effective in children but less effective in adults. Our hypothesis is that this relative failure is due to adults having enough anti-flu IgA antibody in nasal secretions to neutralize the weakened vaccine virus.
This is a VA-based study to evaluate serum and nasal wash antibody responses to seasonal LAIV of healthy Veterans and VA employees between the ages of 20 and 49 years old. Specific Aims 1. The primary aim of the study is to evaluate whether people with high mucosal IgA antibodies against flu have a lower immune response to the seasonal LAIV. 2. The secondary objective is to determine whether the nasal wash viral neutralization data predicts LAIV immunization failures.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
5
All participants will be given FluMist.
Malcom Randall VA Medical Center
Gainesville, Florida, United States
IgA Antibody Titers
Time frame: Change from baseline in antibody titer at 6 weeks
Serum Antibody Response to LAIV
Time frame: Change from baseline in serum antibody response at 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.